Long-Term Survivorship After Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies The CHAI platform extracted quantitative histomorphologic features from whole-slide images of ...

Every decision in drug development carries weight. The right biomarker insights can make those decisions more confident and data-driven. In this white paper, experts from AstraZeneca, Johnson & ...

Priya Hays, Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and ...

Explore what is driving progress in neurological biomarker research today, from emerging technologies to clinical translation ...

OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a ...

Biomarker tests analyze a patient's underlying biology to help clinicians diagnose disease, monitor progression and identify best treatment options.